Fig. 3From: Increased acquired protease inhibitor drug resistance mutations in minor HIV-1 quasispecies from infected patients suspected of failing on national second-line therapy in South AfricaPredicted level of resistance to different antiretroviral drugs based on the Stanford HIVDBBack to article page